Incyte (INCY) PT Raised to $127 at UBS, Neutral Rating Maintained
Tweet Send to a Friend
UBS analyst Ashwani Verma raised the price target on Incyte (NASDAQ: INCY) to $127.00 (from $113.00) while maintaining a Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




